Figure 3.
Patomechanisms inducing an increased possibility of COVID-19 infection in diabetic patients. Antidiabetic treatment, especially combined with other drugs, leads to overexpression of the ACE-2 receptor—a gateway for COVID-19. Deterioration of immune system function in diabetes facilitates the infection and increases its severity.